William Le Gallou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
William Le Gallou has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Abha Anshu Gupta
Division of Haematology/Oncology Princess Margaret Cancer Center, The Hospital for Sick Children Toronto Ontario Canada
1 shared publication - Christina Coleman
Pediatric Hematology and Oncology, Children Hospital, Montreal, Canada
1 shared publication - Dardye Eugène
Division of Pediatric Endocrinology, CHUL-Laval, Quebec City, QC G1V 0A6, Canada
1 shared publication - Hallie Coltin
Department of Pediatric Hematology/Oncology, CHU Sainte Justine, Université de Montréal, Montréal, QC H3C 3A7, Canada
1 shared publication - Laurence Allain
Faculty of Medicine, Laval University, Quebec City, QC G1V 0A6, Canada
1 shared publication - Samuele Renzi
Faculty of Medicine, Laval University, Quebec City, QC G1V 0A6, Canada
1 shared publication
Latest Publications
- Open Access
Significant Response to Denosumab Yet with Severe Rebound Hypercalcemia in a 9-Year-Old Boy with Aneurysmal Bone Cyst: A Case Report
A 9-year-old boy presented with edema of the left cheek. He was diagnosed with a large aneurysmal bone cyst of the mandibular bone. Off-label treatment with denosumab for 17 months resulted in a significant reduction in the lesion. Five months after discontinuing denosumab, the patient developed severe rebound hypercalcemia and acute kidney injury, which resolved with corticosteroids. Two years after treatment discontinuation, the lesion continues to decrease in size. This case highlights the efficacy of denosumab as an off-label treatment for aneurysmal bone cysts, though it can be associated with hypercalcemia and acute kidney injury. We conclude that the use of denosumab should be considered on a case-by-case basis, with regular monitoring for side effects.
Open AccessSignificant Response to Denosumab Yet with Severe Rebound Hypercalcemia in a 9-Year-Old Boy with Aneurysmal Bone Cyst: A Case Report
A 9-year-old boy presented with edema of the left cheek. He was diagnosed with a large aneurysmal bone cyst of the mandibular bone. Off-label treatment with denosumab for 17 months resulted in a significant reduction in the lesion. Five months after discontinuing denosumab, the patient developed severe rebound hypercalcemia and acute kidney injury, which resolved with corticosteroids. Two years after treatment discontinuation, the lesion continues to decrease in size. This case highlights the efficacy of denosumab as an off-label treatment for aneurysmal bone cysts, though it can be associated with hypercalcemia and acute kidney injury. We conclude that the use of denosumab should be considered on a case-by-case basis, with regular monitoring for side effects.